Scope of Outcomes in Trials and Observational Studies of Interventions Targeting Medication Adherence in Rheumatic Conditions: A Systematic Review
Authors:
- Ayano KellyAKAyano Kelly
- Luke Crimston-SmithLCLuke Crimston-Smith
- Allison TongATAllison Tong
- Susan J. BartlettSBSusan J. Bartlett
- Charlotte L. BekkerCBCharlotte L. Bekker
- Robin ChristensenRCRobin Christensen
- Mary A. De VeraMVMary A. De Vera
- Maarten de WitMWMaarten de Wit
- Vicki EvansVEVicki Evans
- Michael GillMGMichael Gill
- Lyn MarchLMLyn March
- Karine ManeraKMKarine Manera
- 15 December 2019
- journal article
- review article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
- Vol. 47 (10) , 1565-1574
Abstract
Objective.: Nonadherence to medications is common in rheumatic conditions and associated with increased morbidity. Heterogeneous outcome reporting by researchers compromises the synthesis of evidence of interventions targeting adherence. We aimed to assess the scope of outcomes in interventional studies of medication adherence.Methods.: We searched electronic databases to February 2019 for published randomized controlled trials and observational studies of interventions with the primary outcome of medication adherence including adults with any rheumatic condition, written in English. We extracted and analyzed all outcome domains and adherence measures with prespecified extraction and analysis protocols.Results.: Overall, 53 studies reported 71 outcome domains classified into adherence (1 domain), health outcomes (38 domains), and adherence-related factors (e.g., medication knowledge; 32 domains). We subdivided adherence into 3 phases: initiation (n = 13 studies, 25%), implementation (n = 32, 60%), persistence (n = 27, 51%), and phase unclear (n = 20, 38%). Thirty-seven different instruments reported adherence in 115 unique ways (this includes different adherence definitions and calculations, metric, and method of aggregation). Forty-one studies (77%) reported health outcomes. The most frequently reported were medication adverse events (n = 24, 45%), disease activity (n = 11, 21%), bone turnover markers/physical function/quality of life (each n = 10, 19%). Thirty-three studies (62%) reported adherence-related factors. The most frequently reported were medication beliefs (n = 8, 15%), illness perception/medication satisfaction/satisfaction with medication information (each n = 5, 9%), condition knowledge/medication knowledge/trust in doctor (each n = 3, 6%).Conclusion.: The outcome domains and adherence measures in interventional studies targeting adherence are heterogeneous. Consensus on relevant outcomes will improve the comparison of different strategies to support medication adherence in rheumatology.Keywords
This publication has 57 references indexed in Scilit:
- Efficacy study of multimedia rheumatoid arthritis patient education programJournal of the American Association of Nurse Practitioners, 2014
- Electronic Monitoring of Oral Therapies in Ethnically Diverse and Economically Disadvantaged Patients With Rheumatoid Arthritis: Consequences of Low AdherenceArthritis & Rheumatism, 2013
- A new taxonomy for describing and defining adherence to medicationsBritish Journal of Clinical Pharmacology, 2012
- The behaviour change wheel: A new method for characterising and designing behaviour change interventionsImplementation Science, 2011
- Effects of pharmaceutical care on adherence and persistence to bisphosphonates in postmenopausal osteoporotic womenJournal of Clinical Pharmacy and Therapeutics, 2010
- Impact of bone marker feedback on adherence to once monthly ibandronate for osteoporosis among Asian postmenopausal womenInternational Journal of Rheumatic Diseases, 2009
- Assessment of adherence to treatment of postmenopausal osteoporosis with raloxifene and/or alfacalcidol in postmenopausal Japanese womenJournal of Bone and Mineral Metabolism, 2009
- A randomized controlled trial of an intervention to reduce low literacy barriers in inflammatory arthritis managementPatient Education and Counseling, 2009
- Providing patients with information about disease‐modifying anti‐rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfactionMusculoskeletal Care, 2008
- Education and Phone Follow-Up in Postmenopausal Women at Risk for OsteoporosisDisease Management and Health Outcomes, 2005